Dr. Bronner’s is donating $1 million a year for the next five years to the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS). The gift comes after MAPS was given the go-ahead by the US Food and Drug Administration (FDA) to begin Phase 3 drug trials of MDMA-assisted psychotherapy for people with treatment-resistant posttraumatic stress disorder (PTSD). Dr. Bronner’s $5 million, five-year pledge is just a portion of a $25 million drug development budget set forth by MAPS t...